Rather than screening an infinite number of hits to find the needle in the haystack, we build molecules rationally from the start. We partner Bionic Biologics™ with leaders in pharma, biotech, and academia.
We’re target-agnostic. Partner with us to tackle any intracellular or extracellular target of interest.
In vitro proof-of-concept can be achieved within weeks of project start.
Ability to rationally “plug and play” a target-binding peptide domain into the bionic scaffold allows independent optimization of potency and pharmacology.
Our platform chemistry leverages validated, high-yield synthetic processes that enable cost-effective large-scale manufacturing.